지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.2
- 수록면
- 1 - 10 (10page)
- DOI
- 10.3346/jkms.2024.39.e52
이용수
초록· 키워드
오류제보하기
Background: Current guidelines recommend using nirmatrelvir-ritonavir for coronavirus disease 2019 (COVID-19) treatment, but its potential drug interactions and contraindications limit its applicability in certain categories of patients. The aim of the study was to evaluate the real-world effectiveness of molnupiravir and nirmatrelvir-ritonavir in managing COVID-19 among hospitalized patients.
Methods: We conducted a retrospective cohort study among hospitalized COVID-19 patients who received molnupiravir or nirmatrelvir-ritonavir and did not require baseline supplemental oxygen from February 2022 to January 2023. We compared the effectiveness of molnupiravir and nirmatrelvir-ritonavir with a focus on disease progression.
Results: The study included 401 high-risk, hospitalized adult COVID-19 patients who received molnupiravir or nirmatrelvir-ritonavir. No significant difference was found in disease progression, the composite outcome of disease progression (4.0% vs. 1.4%, P = 0.782), and O2 supplementation via nasal prong (21.8% vs. 14.8%, P = 0.115) between the patients treated with molnupiravir and those treated with nirmatrelvir-ritonavir. This finding was similar after 1:1 propensity-score matching. In the multivariate analysis, molnupiravir treatment was not significantly associated with progression to severe disease.
Conclusion: In conclusion, our findings suggest that similar to nirmatrelvir-ritonavir, molnupiravir has a distinct potential role in COVID-19 treatment, transcending its current perceived status as only a secondary option.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Nirmatrelvir/Ritonavir Prescription Rate and Outcomes in Coronavirus Disease 2019: A Single Center Study
Infection and Chemotherapy
2022 .12
-
Effect of Paxlovid in COVID-19 treatment during the periods of SARS-CoV-2 Omicron BA.5 and BN.1 subvariant dominance in the Republic of Korea: a retrospective cohort study
Osong Public Health and Research Persptectives
2024 .04
-
Short-Term Effectiveness of Oral Nirmatrelvir/Ritonavir Against the SARS-CoV-2 Omicron Variant and Culture-Positive Viral Shedding
Journal of Korean Medical Science
2023 .02
-
Could Molnupiravir Be the First-Line Alternative Oral Antiviral Agent for COVID-19 Patients at High Risk?
Journal of Korean Medical Science
2024 .02
-
The Pivotal Role of Molnupiravir in Protecting High-Risk Populations in the Endemic Era of COVID-19: Insight from Real-World Evidence
Infection and Chemotherapy
2024 .03
-
Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
Kidney Research and Clinical Practice
2022 .11
-
COVID-19
International Neurourology Journal
2020 .01
-
Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID
Infection and Chemotherapy
2024 .03
-
Can Panax ginseng help control cytokine storm in COVID-19?
Journal of Ginseng Research
2022 .05
-
코로나바이러스감염증-19 치료제 현황
보건의료기술평가
2020 .01
-
Delays in Intracerebral Hemorrhage Management Is Associated with Hematoma Expansion and Worse Outcomes: Changes in COVID-19 Era
Yonsei Medical Journal
2021 .10
-
A Review of Recent Trend of COVID-19 Infection and Correlation with Pulmonary Function
대한의생명과학회지
2020 .09
-
Risk factors for intensive care unit admission and mortality in hospitalized COVID-19 patients
Acute and Critical Care
2020 .01
-
Infection prevention measures and outcomes for surgical patients during a COVID-19 outbreak in a tertiary hospital in Daegu, South Korea: a retrospective observational study
Journal of Yeungnam Medical Science
2022 .07
-
Prognostic Factors for Severe Coronavirus Disease 2019 in Daegu, Korea
Journal of Korean Medical Science
2020 .01
-
Experience of patients diagnosed as asymptomatic COVID-19 after dental treatment
Maxillofacial Plastic Reconstructive Surgery
2021 .12
-
만성 코로나19 증후군 시대를 위한 보건의료 대응 방안
대한의사협회지
2023 .01
-
Vaccine hesitancy in patients with COVID-19 who have back pain
Osong Public Health and Research Persptectives
2023 .04
-
COVID-19 확진 확자의 응급수술
한국의료시뮬레이션학회지
2021 .12
-
COVID-19 전후 한방병원 침구의학과 내원 환자들에 대한 비교 분석 - 일개 대학병원을 중심으로 -
대한한의학회지
2021 .06
최근 본 자료
댓글(0)
0